| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 76, 1153-1159, Copyright © 1993 by Endocrine Society
ARTICLES |
CA Conover and MC Kiefer
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905.
U-2 human osteosarcoma cells secrete a 29/32/34 kilodalton (kDa) insulin-like growth factor binding protein (IGFBP) identified as O- glycosylated IGFBP-5. Treatment of U-2 cells with IGF-I markedly increased medium levels of IGFBP-5 in a concentration- and time- dependent manner; other skeletal regulatory factors (GH, insulin, PTH, dexamethasone, beta-estradiol, 1,25-dihydroxyvitamin D3, transforming growth factor-beta) had no effect. IGF-I increased IGFBP-5 levels in the culture medium 10-fold without influencing IGFBP-5 messenger RNA abundance. IGF-I, IGF-II, and the IGF-I analog [1-27Gly(4)38-70] IGF-I bound IGFBP-5 with high affinity and, when added to U-2 cultures, effectively promoted IGFBP-5 accumulation in the medium. On the other hand, des(1-3)IGF-I and [QAYL]IGF-I, IGF-I analogs that did not bind IGFBP-5, failed to elicit an increase in medium IGFBP-5. Cell-free incubation of recombinant human (rh) IGFBP-5 in U-2 conditioned medium resulted in a marked reduction of detectable rhIGFBP-5; the presence of IGF-I or IGF-II peptide partially prevented this decrease. By immunoblot analysis, loss of intact rhIGFBP-5 (29-kDa unreduced, 34-kDa reduced) coincided with the appearance of a 16-kDa proteolytic fragment. U-2 conditioned medium contained immunoreactive IGFBP-5 at 29- 34-kDa, 20-kDa, 17-kDa, and 16-kDa. Endogenous IGFBP-5 inhibited IGF-I but not des(1-3)IGF-I-stimulated U-2 cell proliferation. In conclusion, IGF peptides can regulate the availability of IGFBP-5 in osteoblast- like cells by impeding IGFBP-5 proteolysis. The biological consequence of increased medium IGFBP-5 appears to be decreased cell responsiveness to IGF-I stimulation.
This article has been cited by other articles:
![]() |
A. Mukherjee and P. Rotwein Insulin-Like Growth Factor-Binding Protein-5 Inhibits Osteoblast Differentiation and Skeletal Growth by Blocking Insulin-Like Growth Factor Actions Mol. Endocrinol., May 1, 2008; 22(5): 1238 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Conover Insulin-like growth factor-binding proteins and bone metabolism Am J Physiol Endocrinol Metab, January 1, 2008; 294(1): E10 - E14. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Graham, D. M. Kilby, S. M. Firth, P. J. Robinson, and R. C. Baxter The in Vivo Phosphorylation and Glycosylation of Human Insulin-like Growth Factor-binding Protein-5 Mol. Cell. Proteomics, August 1, 2007; 6(8): 1392 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reichling, K. H. Goss, D. J. Carson, R. W. Holdcraft, C. Ley-Ebert, D. Witte, B. J. Aronow, and J. Groden Transcriptional Profiles of Intestinal Tumors in ApcMin Mice are Unique from those of Embryonic Intestine and Identify Novel Gene Targets Dysregulated in Human Colorectal Tumors Cancer Res., January 1, 2005; 65(1): 166 - 176. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Yin, Q. Xu, and C. Duan Paradoxical Actions of Endogenous and Exogenous Insulin-like Growth Factor-binding Protein-5 Revealed by RNA Interference Analysis J. Biol. Chem., July 30, 2004; 279(31): 32660 - 32666. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Hoang, J. D'Cunha, M. G. Kratzke, C. E. Casmey, S. P. Frizelle, M. A. Maddaus, and R. A. Kratzke Gene Expression Profiling Identifies Matriptase Overexpression in Malignant Mesothelioma Chest, May 1, 2004; 125(5): 1843 - 1852. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Spicer Proteolytic Degradation of Insulin-Like Growth Factor Binding Proteins by Ovarian Follicles: A Control Mechanism for Selection of Dominant Follicles Biol Reprod, May 1, 2004; 70(5): 1223 - 1230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Palermo, P. Manduca, E. Gazzerro, L. Foppiani, D. Segat, and A. Barreca Potentiating role of IGFBP-2 on IGF-II-stimulated alkaline phosphatase activity in differentiating osteoblasts Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E648 - E657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-C. C. Yeh and J. C. Lee Identification of an Osteogenic Protein-1 (Bone Morphogenetic Protein-7)-Responsive Element in the Promoter of the Rat Insulin-Like Growth Factor-Binding Protein-5 Gene Endocrinology, September 1, 2000; 141(9): 3278 - 3286. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.S. Gadd, J.C. Osgerby, and D.C. Wathes Regulation and Localization of Insulin-Like Growth Factor Binding Protein-5 Gene Expression in the Uterus and Placenta of the Cyclic and Early Pregnant Ewe Biol Reprod, May 1, 2000; 62(5): 1415 - 1421. [Abstract] [Full Text] |
||||
![]() |
V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text] |
||||
![]() |
T. Thomas, F. Gori, T. C. Spelsberg, S. Khosla, B. L. Riggs, and C. A. Conover Response of Bipotential Human Marrow Stromal Cells to Insulin-Like Growth Factors: Effect on Binding Protein Production, Proliferation, and Commitment to Osteoblasts and Adipocytes Endocrinology, November 1, 1999; 140(11): 5036 - 5044. [Abstract] [Full Text] |
||||
![]() |
C. Ji, Y. Chen, M. Centrella, and T. L. McCarthy Activation of the Insulin-Like Growth Factor-Binding Protein-5 Promoter in Osteoblasts by Cooperative E Box, CCAAT Enhancer-Binding Protein, and Nuclear Factor-1 Deoxyribonucleic Acid-Binding Sequences Endocrinology, October 1, 1999; 140(10): 4564 - 4572. [Abstract] [Full Text] |
||||
![]() |
S. M. Leal, S. S. Huang, and J. S. Huang Interactions of High Affinity Insulin-like Growth Factor-binding Proteins with the Type V Transforming Growth Factor-beta Receptor in Mink Lung Epithelial Cells J. Biol. Chem., March 5, 1999; 274(10): 6711 - 6717. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Bushman and J. F. Kuemmerle IGFBP-3 and IGFBP-5 production by human intestinal muscle: reciprocal regulation by endogenous TGF-beta 1 Am J Physiol Gastrointest Liver Physiol, December 1, 1998; 275(6): G1282 - G1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gabbitas and E. Canalis Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts Am J Physiol Endocrinol Metab, August 1, 1998; 275(2): E222 - E228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sunic, J. D. McNeil, T. E. Rayner, D. L. Andress, and D. A. Belford Regulation of Insulin-Like Growth Factor-Binding Protein-5 by Insulin-Like Growth Factor I and Interleukin-1{alpha} in Ovine Articular Chondrocytes Endocrinology, May 1, 1998; 139(5): 2356 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Twigg and R. C. Baxter Insulin-like Growth Factor (IGF)-binding Protein 5 Forms an Alternative Ternary Complex with IGFs and the Acid-labile Subunit J. Biol. Chem., March 13, 1998; 273(11): 6074 - 6079. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text] |
||||
![]() |
E. M. Zimmermann, L. Li, Y. T. Hou, M. Cannon, G. M. Christman, and K. N. Bitar IGF-I induces collagen and IGFBP-5 mRNA in rat intestinal smooth muscle Am J Physiol Gastrointest Liver Physiol, October 1, 1997; 273(4): G875 - G882. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Franchimont, D. Durant, and E. Canalis Interleukin-6 and Its Soluble Receptor Regulate the Expression of Insulin-Like Growth Factor Binding Protein-5 in Osteoblast Cultures Endocrinology, August 1, 1997; 138(8): 3380 - 3386. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. McCarthy, S. Casinghino, D. W. Mittanck, C.-H. Ji, M. Centrella, and P. Rotwein Promoter-dependent and -independent Activation of Insulin-like Growth Factor Binding Protein-5 Gene Expression by Prostaglandin E(2) in Primary Rat Osteoblasts J. Biol. Chem., March 22, 1996; 271(12): 6666 - 6671. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Duan, S. B. Hawes, T. Prevette, and D. R. Clemmons Insulin-like Growth Factor-I (IGF-I) Regulates IGF-binding Protein-5 Synthesis through Transcriptional Activation of the Gene in Aortic Smooth Muscle Cells J. Biol. Chem., February 23, 1996; 271(8): 4280 - 4288. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Canalis and B. Gabbitas Skeletal Growth Factors Regulate the Synthesis of Insulin-like Growth Factor Binding Protein-5 in Bone Cell Cultures J. Biol. Chem., May 5, 1995; 270(18): 10771 - 10776. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Overgaard, H. B. Boldt, L. S. Laursen, L. Sottrup-Jensen, C. A. Conover, and C. Oxvig Pregnancy-associated Plasma Protein-A2 (PAPP-A2), a Novel Insulin-like Growth Factor-binding Protein-5 Proteinase J. Biol. Chem., June 8, 2001; 276(24): 21849 - 21853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |